News at a glance.

Press releases

All resultsAd hoc announcement pursuant to Art. 53 LRPress release
  • Ad hoc announcement pursuant to Art. 53 LR, Thursday, 11 May 2023

    Competition authorities in Switzerland and Austria have approved the planned joint venture between Galenica Ltd. and Shop Apotheke Europe N.V. This clears the way for the formation of Switzerland’s leading online pharmacy. The transaction establishing the joint venture will be completed on 16 May 2023.

    At the end of March 2023, Galenica and Shop Apotheke Europe announced they were to combine the business activities of the specialty pharmacy Mediservice Ltd. and the online pharmacy into a joint venture as part of a strategic partnership. The planned joint venture had, up until now, been subject to approval by the competition authorities.

  • Press release, Wednesday, 3 May 2023

    The shareholders elect Markus R. Neuhaus as the new Chair of the Board of Directors and approve all proposals

    The sixth Annual General Meeting of Galenica Ltd. was held on 3 May 2023 at the Kursaal in Bern. The shareholders approved all the proposals of the Board of Directors. They also approved the dividend proposal of CHF 2.20 per share, +5% on the previous year. The Annual General Meeting also elected Dr Markus R. Neuhaus as the new Chair of the Board of Directors and Prof. Dr med. Solange Peters and Jörg Zulauf as new members of the Board of Directors.
  • Press release, Wednesday, 19 April 2023

    Today, Galenica successfully placed a fixed rate bond of over CHF 240 million. The bond has a term of 6.5 years and an annual coupon of 2.35%. The income from the transaction will be used for refinancing a maturing bond and for general corporate purposes.


  • News, Tuesday, 8 November 2022

    In 2023, Galenica will grant all its employees a fixed cost-of-living adjustment. It is investing over CHF 14 million, thus increasing the payroll for its employees by a total of 3.1 per cent. Additional measures are being implemented for pharmacy staff to increase its attractiveness as an employer.

    All employees of the Galenica Group with a monthly salary of up to CHF 5,000 will receive a monthly salary increase of CHF 150. Employees with a monthly salary of over CHF 5,000 will receive CHF 100 per month (based on a 100% workload). By providing fixed and graduated cost-of-living adjustments, Galenica is sending a clear signal to its employees who are particularly affected by high inflation.

    In addition, Galenica is reaffirming its intention to address the shortage of skilled workers in the healthcare industry with additional measures for pharmacy staff.

    In pharmacies, entry-level salaries will be increased to CHF 4,100 to 4,500, depending on the region and canton. The recommendations of the cantonal pharmacists' associations will be used as a basis.
    The benchmark salaries for employees with work experience will be increased on the basis of the new entry-level salaries.

    Assuming a specific role by pharmacy specialists and thus taking on more responsibility – such as training apprentices – will in future be rewarded with position-related bonuses.

    The attractiveness as an employer is further increased with flat-rate mobility allowances, allowances for acting as a stand-in and team bonuses.

    Galenica is taking a further step towards covering the need for specialist staff in the future by providing a fixed cost-of-living adjustment for all employees as well as additional attractive measures for the pharmacy staff.

  • News, Wednesday, 21 September 2022

    Omni-channel – i.e. the link between online and offline – is a key element of the Galenica strategy. Contrary to earlier expectations, the Careproduct product range cannot be optimally integrated at Galenica. For this reason, Galenica is selling its subsidiary Careproduct to SAB Management Holding Ltd. and its owner Bruno Sauter, effective 20 September 2022.
  • News, Thursday, 8 September 2022

    After around 40 months of construction, Galexis opens the modernised distribution centre in Lausanne-Ecublens.

Subscribe to news

Media conferences and events


«Our communication focuses on the added value that we offer in the Galenica network for our customers and the Swiss healthcare system.»

Christina Hertig, Head of Corporate Communications

Media inquiries

Galenica Ltd.
Untermattweg 8
3027 Bern

Tel. +41 58 852 85 17